A detailed history of Hussman Strategic Advisors, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Hussman Strategic Advisors, Inc. holds 50,400 shares of NVO stock, worth $5.3 Million. This represents 1.56% of its overall portfolio holdings.

Number of Shares
50,400
Previous 42,000 20.0%
Holding current value
$5.3 Million
Previous $6 Million 0.1%
% of portfolio
1.56%
Previous 1.71%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$119.07 - $145.42 $1 Million - $1.22 Million
8,400 Added 20.0%
50,400 $6 Million
Q2 2024

Aug 01, 2024

BUY
$122.71 - $146.91 $1.29 Million - $1.54 Million
10,500 Added 33.33%
42,000 $6 Million
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $3.22 Million - $4.28 Million
31,500 New
31,500 $4.04 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $237B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hussman Strategic Advisors, Inc. Portfolio

Follow Hussman Strategic Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.